Safety and Early Efficacy Outcomes for Lentiviral Fibroblast Gene Therapy in Recessive Dystrophic Epidermolysis Bullosa
JCI insight - United States
doi 10.1172/jci.insight.126243
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 6, 2019
Authors
Publisher
American Society for Clinical Investigation